Second edition of the Milan System for Reporting Salivary Gland Cytopathology: Refining the role of salivary gland FNA

Author:

Rossi Esther Diana1ORCID,Baloch Zubair2,Barkan Guliz3ORCID,Foschini Maria Pia4ORCID,Kurtycz Daniel5ORCID,Pusztaszeri Marc6ORCID,Vielh Philippe7,Faquin William C.8ORCID

Affiliation:

1. Division of Anatomic Pathology and Histology Catholic University of Sacred Heart “Agostino Gemelli” School of Medicine Rome Italy

2. Department of Pathology and Laboratory Medicine Hospital of the University of Pennsylvania Philadelphia Pennsylvania USA

3. Guliz Barkan Department of Pathology Loyola University School of Medicine Maywood Illinois USA

4. Maria Pia Foschini Unit of Anatomic Pathology at Bellaria Hospital Department of Biomedical and Neuromotor Sciences University of Bologna Bologna Italy

5. Department of Pathology and Laboratory Medicine University of Wisconsin School of Medicine and Public Health Madison Wisconsin USA

6. Division of Pathology Jewish General Hospital and McGill University Montreal Quebec Canada

7. Department of Pathology Medipath and American Hospital of Paris Paris France

8. Department of Pathology Massachusetts General Hospital and Harvard Medical School Boston Massachusetts USA

Abstract

AbstractThe use of standardized reporting systems for non‐gynecologic cytopathology has made enormous gains in popularity during the past decade, including for thyroid fine‐needle aspiration, urine cytology, serous effusions, pancreas, lymph nodes, lung, and more. In February 2018, the first edition Atlas of the Milan System for Reporting Salivary Gland Cytopathology (MSRSGC) was published. The MSRSGC defines six diagnostic fine‐needle aspiration categories encompassing the spectrum of non‐neoplastic, benign, and malignant lesions of the salivary glands. The goal of the MSRSGC is to combine each diagnostic category with a defined risk of malignancy and a specific clinical and/or surgical management algorithm. Since its initial publication in 2018, more than 200 studies and commentaries have been published confirming the role of the MSRSGC. The second edition of the MSRSGC, published in July 2023, includes refined risks of malignancy based on systematic reviews and meta‐analyses, a new chapter summarizing the use of salivary gland imaging, new advances in ancillary testing, and updates in nomenclature.

Publisher

Wiley

Subject

Cancer Research,Oncology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3